ELV vs TCRX · P/E 18, rev $199.13B vs rev $2.0M
Elevance Health Inc (ELV) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the ELV and TCRX stock pages for the full models.
Not investment advice.